2013 Annual Event Summary
AIMBE’s Annual Event is our premiere conference during which the top leaders in medical and biological engineering across all arenas—academic, industry, government—gather for three days of cutting edge programming, spectacular social events, and a chance to welcome the newest AIMBE Fellows. Conference highlights included a spectacular banquet hosted by AIMBE leadership with a special tribute to Wallace Coulter. See highlights including the President’s Panel featuring the rare gathering of three university presidents.
A Call to Action – Sustaining America’s Leadership in Life Sciences
This white paper was developed from the panel discussion (video below) entitled “The Biotechnology Agenda for the Next 365 Days” from AIMBE’s Annual Event in February 2013 in Washington, DC. It includes a detailed “Call to Action” for five initiatives: Regulatory, Reimbursement Reform, Federal Funding for Life Sciences, Workplace Development in STEM, and Private Funding/Tax Reform.
Videos
Printed Program
Sessions
President's Panel
The President’s Panel: The Role of Biomedical Engineering in Universities & Society
Session Chair: Kenneth Lutchen, Ph.D., Dean, Boston University College of Engineering, Past-President, AIMBE
- Robert A. Brown, Ph.D., President, Boston University
- Mary Sue Coleman, Ph.D., President, University of Michigan
- Ronald J. Daniels, President, The Johns Hopkins University
Biotech Agenda
The Biotechnology Agenda for the Next 365 Days
Session Chair: Bill Hawkins, Chief Executive Officer, Immucor, Inc., President-Elect, AIMBE
- Andrew von Eschenbach, M.D., President, Samaritan Health Initiatives, and Former Commissioner, Food and Drug Administration
- Peter Lange, Ph.D., Provost, Duke University
- Roger Perlmutter, M.D., Ph.D., Consultant and Former Executive Vice President of Research and Development, AmGen, Inc.
- Stephen J. Ubl, President and Chief Executive Officer, AdvaMed
Engineering Immunity
Engineering Immunity
Session Chair: Jeffrey Hubbell, Ph.D., Professor, École Polytechnique Federale de Lausanne
- George Georgiou, Ph.D., Cockrell Family Regents Chair in Engineering, University of Texas, Austin
- Darrell J. Irvine, Ph.D., Associate Professor of MSE and Biological Engineering, Investigator, Howard Hughes Medical Institute, Massachusetts Institute for Technology
- Melody Swartz, Ph.D., Head of the Laboratory of Lymphatic and Cancer Bioengineering, École Polytechnique Federale de Lausanne
Third World First World
Designing Medical Technologies for the Third World: Applying to the First World
Session Chair: Ling Wong, Ph.D., Program Officer, Bill & Melinda Gates Foundation
- Melissa Driver Beard, Executive Director and Chief Executive Officer, Engineering World Health
Bio-inspired Engineering
Bio-inspired Engineering
Session Chair: Noubar Afeyan, Founder, Managing Partner, and Chief Executive Officer, Flagship Ventures